Aditxt, Inc. entered into an Asset Purchase Agreement with Pearsanta, Inc. and MDNA Life Sciences, Inc. for the acquisition of certain assets relating to MDNA's early cancer detection platform, with consideration consisting of upfront working capital payment, stock, warrants, and preferred stock.